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ABSTRACT 
O&@ctive: With a goal to establish strategies for improving blood 
safety in resource-limited conditions, the outcome of blood 
transfusion in a hospital setting of Cameroon was examined. 
Methods: A 5-year descriptive and prospective study was con- 
ducted in which information on donor blood and recipients was 
obtained by direct patient observation and by examining patient 
notes in the various services of the hospital and records from 
the blood bank. 
Results: Of 40,134 donations, 35,318 (88%) were from relatives 
or friends of recipients, Only 80% of all donated blood was 
considered safe for distribution. An average of about 20% of 
donated blood was rejected each year for positive human 
immunodeficiency virus (HIV) or hepatitis B antigen results, 
Other infections were not screened for. More than 50% of trans- 
fusions within the hospital were associated with an unfavor- 
able outcome, predominantly febrile reactions and urticaria 
(40.1% and 19.4%, respectively). Acute intravascular hemoly- 
sis, circulatory overload, and deaths occurred in 0.01 %, 0.04%, 
and 0.14% of cases, respectively. A case of post-transfusion 
HIV infection was also detected. 
Conclusions: Blood transfusion is still unsafe in many resource- 
limited communities of developing countries. However, it is pos- 
sible to reduce some of these complications without 
sophisticated technology. Efforts to recruit more benevolent 
and autologous donors in the communities are essential. 
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The use of blood and blood products is an indispensable 
aspect of therapeutic medicine; so much so that blood 
transfusion currently is considered a full sub-speciality in 
its own right. Nevertheless, this important therapy may 
be associated with complications, such as immunologic, 
infectious, or metabolic accidents. These complications 
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are sometimes immediate (occurring during or just after 
transfusion) and are sometimes delayed (occurring days 
or weeks later). Despite all precautions taken to render 
blood 100% safe, most countries of the developing world 
still report the highest numbers of fatal complications 
linked to blood transfusion therapy.‘x2 The predominance 
of hospital-based blood banks in the communities rely 
on family donors rather than regular benevolent donors; 
this aggravates the situation3 This analysis was under- 
taken to evaluate the outcome of blood transfusion in a 
hospital setting of Yaounde, Cameroon, where a blood 
bank of this type functions with limited resources and 
structures and few trained personnel. 
DESIGN AND METHODS 
A 5-year descriptive and prospective study was carried 
out in one of the biggest teaching hospitals of Cameroon, 
Hopital CentralYaoundC @ICY) between 1994 and 1998. 
The hospital currently has a bed capacity of 478 beds. It 
also caters for the medical needs of most of the city of 
Yaounde and its environs. 
In Cameroon, each hospital or Health Institution tends 
to run an autonomous blood supply unit (a mini blood 
bank), because there is no national blood transfusion ser- 
vice. Thus, in addition to all the other services of HCY, 
there is a blood bank from which the majority of blood 
for transfusion is distributed to centers that serve the pop- 
ulation ofYaounde and to neighboring health institutions. 
Since there is no temperature-controlled centrifuge avail- 
able, sedimentation by gravity is the procedure used to 
obtain red cell concentrates, and when they are required, 
transfusion of the unit is interrupted once the red cells 
have all been transfused. The screening tests routinely 
done on donated blood include screening for infectious 
diseases (Australian antigen for hepatitis B [HbsAg] , human 
immunodeficiency virus [HIV], and Treponema pallidurn 
[syphilis]) and Al30 and Rhesus D (RhD) blood group test- 
ing. Screening for hepatitis C virus (HCV), cytomegalovirus 
(C&IV), and others is not carried out in this center. A minor 
compatibility test is always performed between the donor 
plasma and patient red cells prior to transfusion, but major 
compatibility testing is not carried out in this center. This 
blood bank tends to keep daily records (registers) of all 
blood donated with respect to the results of screening 
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Year of 
Collection 
Units Collected 
n = 40,134 
Table 1. Repartition of All Blood Collected between 1994 and 1998 
Units Distributed Units Used within HCY H/V-Positive Units 
n =32,707(%) n = 26,973 (%) n = 2,038 (%) 
HbsAg-Positive 
n = 5,989 (%) 
1994 8,261 7,047 (85.30) 5,911 (83.87) 338 (4.10) 876 (10.60) 
1995 7,679 6,124 (79.75) 5,270 (86.05) 330 (4.30) 1,225(15.95) 
1996 7,570 5,596 (73.92) 4,533 (81.00) 439 (5.80) 1,535 (20.28) 
1997 6,225 6,621 (80.50) 5,615 (84.80) 469 (5.70) 1,135 (13.80) 
1998 8,399 6,719 (80.00) 5,644 (84.00) 462 (5.50) 1,218(14.50) 
Mean 8,026.80 6,421.40 (79.89) 5,394.60 (83.94) 407.60 (5.08) 1,197.80(15.02) 
SD 374.90 567.80 (4.04) 532.75 (1.86) 68.10 (0.81) 235.70 (3.52) 
*Percentage of total distribution. SD = standard deviation. 
tests, blood group, blood request forms, and blood distri- 
bution. The destination of any blood is usually specified; 
thus, with some effort, it is possible to trace it to the recip- 
ient. Any incidents during transfusion tend to be reported 
to the blood bank or recorded in the patient notes, but 
there is no organized system available to ensure that no 
information is lost. 
Between January 1994 and December 1998 records 
for all blood donations were examined for relevant infor- 
mation on the various screening tests performed on each 
pint of blood, their Al30 or Rh blood groups, the total 
number of pints distributed or eliminated, and any acci- 
dents or incidents associated with the transfusions under- 
taken within the hospital. Information was also obtained 
from patient records, after verbal consent from the heads 
of the various services, on the management and evolution 
of the complications that occurred as well as the final 
outcome of the transfusion. All relevant data were copied 
on to pre-established work sheets for analyses. 
RESULTS 
Of 40,134 units of blood collected over the past 5 years, 
35,3 18 (88%) were donated by family members or friends 
of the recipients. Only 32,107 pints (79.89 + 4.04% of 
total blood collected) were considered safe and distrib- 
uted for use, an average of 6421 It 567.8 units per 
annum. Approximately 20% of all donations were rejected 
each year after screening for infectious agents: 5.08 2 
0.81% with HIV antibodies detected and 15.02 t 3.52% 
positive for the HbsAg screening test. A total of 26,973 
pints (84% of all the distributed blood) was used within 
the hospital itself (Table 1); the rest was distributed to 
neighboring health centers and hospitals. During the 
study period, more than 50% of the transfusions were 
associated with an unfavorable outcome, with a peak 
noticed in 1995 (85% of all transfusions) and a steady 
decline over the following years (Table 2). 
Gender and Age Distribution 
Among the blood recipients, 59.2% were female and 
40.8% male. Patients younger than 15 years of age (pedi- 
atric ages) constituted 63.5% of all recipients. 
Blood-Group Distribution 
Blood groups 0, A, B, and AB were respectively distributed 
to 6O%, 22%, 14%, and 4% of the recipients. About 2% of 
cases were Rh negative. 
Indications for Transfusion 
Most transfusions were administered in pediatric cases 
(~15 y) (17,128 units, 63.5% of all blood used within 
HO. Indications for transfusion in this group included 
Table 2. Unfavorable Outcome of Transfusions between 1994 and 1998 in HBpital Central YaoundB, Cameroon 
Year 
Unfavorable Outcome 
n = 16,107(59.7%) 
Total units transfused 
1994 1995 1996 1997 1998 
n = 3,798 (64.2%) n = 4,520 (85.7%) n = 3,170 (69.9%) n = 2,637 (46.9%) n = 1,982 (35.1%) 
n = 26,973(100%) 
Febrile reactlons 
n = 10,819(40.10%) 
Urticaria n = 5,233 (19.40%) 
Acute hemolytic reactions 
n = 4 (0.01%) 
Delayed hemolytic reactions 
n=O 
Infections n = 1 (0.003%) 
Circulatory overload 
n = 12 (0.04%) 
Hypothermian = 0 
Death n = 38 (0.14%) 
5,911 5,270 4,533 5,615 5,644 
3,007 2,900 2,068 1,501 
781 
1,343 
1,606 1,089 1,125 632 
2 1 - - 1 
- - 
- - 1 
2 4 3 3 
- - - 
6 9 10 8 5 
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malaria (as the sole cause of anemia) in 387% of cases; 
sickle cell anemia in 35.5% of cases, and nutritional ane- 
mias in 11.6% of cases. The rest of the pediatric cases 
(14.2%) were transfused for other causes, such as infec- 
tions, including HIV and acquired immunodeficiency syn- 
drome (AIDS), intestinal parasites, and childhood leukemia 
and other malignancies. 
About 18% of blood (4855 units) was distributed to 
recipients from the obstetrics and gynecology unit and 
was transfused mainly alter hemorrhage from abortion, 
ruptured extra-uterine pregnancy and other third- 
trimester bleeding, and following cesarean section. The 
remaining 18.5% (4990 units) was used in the medicine 
and surgery units, usually in recipients with digestive 
hemorrhages, cancers, AIDS, and other chronic diseases 
associated with anemia. A few cases in surgery were trans- 
fused as a preventive measure prior to surgery. 
Previous Transfusions 
Most of the patients with sickle cell anemia (93%) had 
received at least one previous transfusion, compared to 
24% of the patients with malaria. The majority of cases 
of hematologic and other malignancies had also previ- 
ously received a transfusion. 
Unfavorable Outcome of Transfusion 
As shown in Table 2, the most frequent unfavorable occur- 
rences noted were febrile reactions (40.1%) and urticaria 
(19.4%). These findings were noted most often in per- 
sons with a history of blood transfusion. These reactions 
usually occurred within the first 60 to 90 minutes after 
the start of transfusion. There were no cases of hypother- 
mia observed. Although relatively rare, an acute hemolytic 
reaction (AHR), from incompatible ABO blood group 
transfusions, was reported in 0.01% of cases; of the four, 
two patients died. Circulatory overload, usually with acute 
pulmonary edema (APE) was noted in 12 recipients 
(0.04%), with a subsequent fatal outcome in seven cases. 
In four cases, APE was attributable to transfusion of whole 
blood to severely chronically anemic patients with heart 
failure and chronic renal failure. Death occurred in 0.14% 
of cases either during or shortly after transfusion (within 
a couple of hours). In patient records, these deaths were 
attributed to a variety of causes, including shock and dis- 
seminated intravascular coagulation (DIG) following AHR, 
acute renal failure, and APE. In one case of sickle cell ane- 
mia, the child died suddenly during the course of the 
transfusion, and no precise cause was determined. 
DISCUSSION 
It is understandable that febrile reactions were the most 
common outcome noted in blood recipients within HCY. 
Febrile reactions, among other causes, may be attribut- 
able to incompatible white cells, owing to release of pyro- 
gens from recipient granulocytes and monocytes. Thus, 
antileukocyte, anti-human leukocyte antigen (HIA) and 
other irregular antibodies are developed, usually in mul- 
tiparous women and those with previous blood transfu- 
sions. Leukocyte depletion is not done at all in Cameroon, 
increasing the risk of antigranulocyte antibodies being 
developed in repeatedly transfused individuals. Further- 
more, donor blood is not screened for malaria parasites. 
Nevertheless, with malaria being endemic in Cameroon, 
the parasite may be transfused directly to recipients at var- 
ious stages of its life cycle within the blood stream, caus- 
ing fever. In a pilot study of the prevalence of malaria 
parasites among donated blood units in a transfusion ser- 
vice, about 80% of the units contained malaria parasites 
(Binam E Personal communication). No case of fever was 
attributed to bacterial pyrogens from transfusion of blood 
contaminated with bacteria. 
The frequent occurrence of urticaria and pruritus, a 
manifestation of allergy, may result from the presence of 
foreign proteins in the donor plasma, because whole 
blood is the major type of blood product transfused in 
HCY (approximately 84%) irrespective of the clinical sta- 
tus of the recipient.* Filarial proteins in donor plasma 
(Loa loa and Onchocerca volvulus infections) may also 
contribute significantly to the occurrence of urticaria and 
pruritus, since these are highly prevalent in Cameroon.5,6 
In addition, blood separation to obtain red cell concen- 
trates currently is entirely dependent on the effect of 
gravity on a unit of whole blood. Sometimes nurses who 
administer blood transfusions do not remember to stop 
the procedure as soon as all red cells have been trans- 
fused. Thus, substantial amounts of plasma and plasma 
proteins are always inevitably transfused. This further 
explains the occurrence of APE in some patients with 
chronic anemia, chronic renal failure, and heart disease.7 
The use of phenotyped red cells in persons who are sub- 
ject to repeated transfusions is not practiced because of 
the limited resources. In 1990, Vichinsky and colleagues 
observed that more alloimmunization with red cell anti- 
bodies occurred in multiply transfused people with hemo- 
globinopathy in Africa.8 This further explains some of 
the transfusion reactions observed in this community. 
The absence of hypothermia observed may be explained 
by the frequent and unacceptable practice in this hospi- 
tal of warming blood units at uncontrolled temperatures 
and duration before use. 
The risk of transmission of various infections through 
blood transfusion is well documented and may account 
for an estimated average of 10% of all HIV infections in 
sub-Saharan Africa.3 A prevalence of 4.1% for HIV infec- 
tion was reported among blood donors in Yaounde in 
1990, this being an increase from 0.36% observed in 1987 
(Sentinel Surveillance of the Ministry of Public Health of 
Cameroon, 1990). Meanwhile a prevalence of 10 to 15% 
for HbsAg was described in blood donors in Yaounde.’ 
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With the possibility of a negative screening test during 
the pre-serologic phase of the HIV cycle, and especially 
with the existence of new strains of the virus (0 and N 
subtypes), a high incidence of transmission should be 
expected. However, only one case of HIV transmission 
through transfusion was recorded in this study. This may 
be explained by the fact that few people are screened for 
HIV as a routine test prior to transfusion and by the pos- 
sible existence of the serologic window in some of the 
donated blood. 
Although no case of HCV infection was recorded in 
this study, screening for this virus is not being carried 
out in this blood bank. A prevalence of 13% in parts of 
Cameroon had been reported,l and screening for the 
HCV in a group of homozygous patients with sickle cell 
anemia who had received several blood transfusions in 
Yaounde showed a prevalence of 23.91% among them.’ 
Thus, it is likely that many get this infection from trans- 
fusions in this setting. In fact it is believed to be respon- 
sible for 80 to 90% of post-transfusion hepatitis.‘O 
No information is available on CMV; human T-cell lym- 
photropic virus type I and type II (HTLV-I and -II), and 
other such infections in this blood bank. Infections such 
as malaria were not included in any records. Cameroon 
is endemic for Plasmodium falciparum malaria”; thus, 
it is not considered cost-effective to screen donor blood 
for malaria parasites prior to transfusion. Nevertheless, 
malaria is believed to be common in this setting follow- 
ing transfusion. 
Four cases of acute hemolytic reaction attributable to 
ABO incompatible blood transfusions were recorded, two 
of which had fatal outcomes. Fatal cases of APE were also 
recorded. These suggest that the human factor (record- 
ing and verification of blood groups, supervision of trans- 
fusion, and intervention at the slightest manifestation. , .) 
has a vital influence on the outcome of blood transfu- 
sion. Major compatibility testing would also reduce the 
prevalence of such accidents. No cases of delayed 
hemolytic reactions were recorded. This may be 
explained by the fact that many patients tend to be lost 
to follow-up. Thus, available information is usually on 
immediate transfusion accidents (same day incidents). In 
most instances the patients may not associate late symp- 
toms with the transfusions. 
aspects of transfusion therapy, and the strict implemen- 
tation of practical international norms would go a long 
way to improve the situation. Blood donations tend to 
be sporadic, and donors are more often family or friends 
of recipients than regular and benevolent donors as rec- 
ommended by the World Health Organization. In addi- 
tion, hospital-based transfusion systems have been shown 
to be not only not economical, as demonstrated by an 
average of 20% bags destroyed annually in this case, after 
testing but also more difficult to manage, and they tend 
to be unsafe.” Although more trained and committed per- 
sonnel are needed in this field to reduce preventable neg- 
ative effects of transfusion, international organizations 
should continue to sponsor and supervise developing 
countries in creating organized national blood transfu- 
sion services to enhance blood safety for all. 
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